
Sign up to save your podcasts
Or
Blunt Business explores the critical issues facing the cannabis industry, focusing on regulation, compliance, and investment, through the lens of the International Cannabis Bar Association (INCBA). David Ruskin, their newly appointed president, shared his insights on the organization's role and the evolving legal and regulatory landscape.
Ruskin highlighted the INCBA's value as a network of experienced professionals dedicated to navigating the complexities of cannabis law. He emphasized the organization's role in providing access to expertise on diverse regulatory standards across different markets, a crucial benefit given the ever-changing rules governing the industry.
The INCBA serves as a central resource for staying informed and connected, offering guidance on navigating the intricate regulatory environment. The conversation addressed the ongoing process of rescheduling cannabis under the Controlled Substances Act.
Ruskin discussed the delays caused by new allegations and the subsequent public comment period, including an interlocutory appeal that further complicates the timeline. The potential impact of the Biden administration's support for rescheduling was explored, along with the possibility of increased DEA involvement in cannabis regulation following rescheduling.
4.1
3838 ratings
Blunt Business explores the critical issues facing the cannabis industry, focusing on regulation, compliance, and investment, through the lens of the International Cannabis Bar Association (INCBA). David Ruskin, their newly appointed president, shared his insights on the organization's role and the evolving legal and regulatory landscape.
Ruskin highlighted the INCBA's value as a network of experienced professionals dedicated to navigating the complexities of cannabis law. He emphasized the organization's role in providing access to expertise on diverse regulatory standards across different markets, a crucial benefit given the ever-changing rules governing the industry.
The INCBA serves as a central resource for staying informed and connected, offering guidance on navigating the intricate regulatory environment. The conversation addressed the ongoing process of rescheduling cannabis under the Controlled Substances Act.
Ruskin discussed the delays caused by new allegations and the subsequent public comment period, including an interlocutory appeal that further complicates the timeline. The potential impact of the Biden administration's support for rescheduling was explored, along with the possibility of increased DEA involvement in cannabis regulation following rescheduling.
7,162 Listeners
24 Listeners
32,535 Listeners
15 Listeners
10 Listeners
564 Listeners
20 Listeners
121 Listeners
13 Listeners
3 Listeners
5 Listeners
272 Listeners
174 Listeners
50 Listeners
2 Listeners
68 Listeners
555 Listeners
51 Listeners
4,740 Listeners
103 Listeners
326 Listeners
211 Listeners
7 Listeners
11 Listeners